Alkermes plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALKS Nasdaq 2836 www.alkermes.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alkermes plc

SNY Stock Falls After Board Suddenly Makes Leadership Change - Feb 13th, 2026 10:55 am
VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales - Feb 13th, 2026 9:53 am
Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss - Feb 13th, 2026 8:33 am
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/Y - Feb 13th, 2026 8:23 am
CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates - Feb 13th, 2026 8:04 am
Alkermes Completes Acquisition of Avadel - Feb 12th, 2026 6:57 am
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - Feb 12th, 2026 5:30 am
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Feb 11th, 2026 2:00 pm
MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA - Feb 11th, 2026 8:45 am
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing - Feb 10th, 2026 2:05 pm
SNY's Rare Disease Drug Wins FDA Breakthrough and Japan Orphan Status - Feb 10th, 2026 8:43 am
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus - Feb 9th, 2026 9:42 am
KOD Stock Up 24% in 3 Months: Here's What You Need to Know - Feb 6th, 2026 9:31 am
How Recent Narcolepsy Data And Avadel Bid Are Shaping The Alkermes ALKS Story - Feb 6th, 2026 7:06 am
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results - Feb 5th, 2026 9:42 am
FDA Rejects AZN's Saphnelo SubQ Formulation, Priority Tag to Datroway - Feb 4th, 2026 8:11 am
Sanofi's Venglustat Meets Primary Endpoints in Gaucher Disease Study - Feb 3rd, 2026 9:59 am
Acadia Expects Negative CHMP Opinion for Rett Syndrome Drug in EU - Feb 3rd, 2026 5:52 am
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome - Feb 2nd, 2026 9:03 am
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year? - Feb 2nd, 2026 7:40 am